Chronic pain is a daily reality for millions of Americans, interfering with their everyday activities and quality of life. An ...

Talking with the North Carolina Harm Reduction Coalition’s Loftin Wilson about the coalition’s work, how the opioid epidemic ...

Trevi Therapeutics is developing nalbuphine ER (Haduvio) for chronic cough in IPF and RCC, targeting unmet medical needs.

The Select Board plans to partner with the Berkshire Regional Planning Commission and Northern Berkshire Community Coalition ...

Listening to a favorite song can trigger a profound emotional response that rivals the feelings produced by biological ...

A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma's latest deal to settle ...

The bill would provide case management, medication for behavioral health therapy and, upon prison release, a 30-day supply of prescription medication.

The effects of Ozempic on grocery spending are obvious; the Harvard Business Review found GLP-1 households are spending up to ...

ENSC READ THE FULL ENSC RESEARCH REPORT Ensysce Biosciences (NASDAQ:ENSC) is a clinical stage company that is developing novel opioids that provide the needed pain relief, while greatly limiting the ...

We aim to provide transparency in how Elevance Health plans address variations in clinical practices to ensure safe, ...

Modern pain epidemiology and neuroscience teach us that pain and suffering are not medical cause and personal effect, but ...

Two research teams 3000 miles apart discover a common bacterium triggering chronic gastrointestinal pain — while developing a ...